On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Save 20% on Press Releases and More with NNW Prime! Click to View Details

NetworkNewsBreaks – Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Anticipates ‘Breakout Year’ in 2021

Imagin Medical (CSE: IME) (OTCQB: IMEXF), a surgical imaging company, expects to achieve important milestones in the year ahead. The company’s proprietary i/Blue Imaging System is designed to significantly enhance surgeons’ ability to visualize and remove cancer cells using blue light by combining advanced optics and light sensors with a contrast imaging agent. The system’s … Continue reading “NetworkNewsBreaks – Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Anticipates ‘Breakout Year’ in 2021”

Imagin Medical Inc.’s (CSE: IME) (OTCQB: IMEXF) Proprietary System Could Help Reduce Bladder Cancer Recurrence

The current standard for bladder cancer visualization, white light, is over three decades old and used in 95% of the bladder cancer surgeries The recurrence rate of bladder cancer is more than 50% due to the inability to see clear margins in the white light surgical standard for visualization Imagin Medical Inc.’s proprietary i/Blue(TM) System … Continue reading “Imagin Medical Inc.’s (CSE: IME) (OTCQB: IMEXF) Proprietary System Could Help Reduce Bladder Cancer Recurrence”

NetworkNewsBreaks – Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Harnesses Blue Light, Innovative Technology for Cancer Imaging

Imagin Medical (CSE: IME) (OTCQB: IMEXF), a surgical imaging company, is harnessing the virtues of blue light in a health-enhancing way. By utilizing the company’s proprietary i/Blue Imaging (TM) System with a contrast agent, surgeons will be able to better visualize the parameters of cancers and develop the appropriate response strategy. Imagin is developing its … Continue reading “NetworkNewsBreaks – Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Harnesses Blue Light, Innovative Technology for Cancer Imaging”

Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Technology Set to Revolutionize Bladder Cancer Visualization

The established and most prominent method of visualizing bladder cancer, white light, lacks the clarity needed to detect finer margins of tumors, which increases the likelihood of recurrence The more recent, improved method, blue light, provides clarity yet introduces cost barriers to adoption Imagin Medical’s i/Blue Imaging(TM) System combines the best of both methods, clarity … Continue reading “Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Technology Set to Revolutionize Bladder Cancer Visualization”

Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Contracts Torrey Hills Capital to Boost Awareness of Its Proprietary Cancer Visualization Technology

Torrey Hills Capital is a leading investor and financial public relations firm that offers extensive expertise in investor relations, corporate communications and other market support operations The services provided to Imagin Medical will be overseen by Torrey Hills Founder and Principal Cliff Mastricola Imagin believes its proprietary imaging technology, the i/Blue Imaging System(TM), will establish … Continue reading “Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Contracts Torrey Hills Capital to Boost Awareness of Its Proprietary Cancer Visualization Technology”

Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Enters 2021 with Optimism for Its Cancer Imaging Technology

Imagin Medical Inc. successfully weathered the 2020 pandemic-induced economic challenges and transitioned its surgical visualization product, the i/Blue Imaging System(TM) from the development stage to manufacturing  and has  after Imagin’s next stage will be supported by a $3 million convertible note, with the final funding tranche expected to close this quarter The i/Blue Imaging System … Continue reading “Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Enters 2021 with Optimism for Its Cancer Imaging Technology”

NetworkNewsBreaks – Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Hires IR Firm Torrey Hills Capital

Imagin Medical (CSE: IME) (OTCQB: IMEXF), a surgical imaging company focused on establishing a new standard of care in visualizing cancer during minimally invasive procedures, today announced its engagement of Rancho Santa Fe, California-based investor relations firm San Diego Torrey Hills Capital, Inc. (“Torrey Hills Capital”) to deliver market awareness and investor relations services to … Continue reading “NetworkNewsBreaks – Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Hires IR Firm Torrey Hills Capital”

Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Offers Significant Advantages Over Current Standard Of Visualizing Bladder Cancer During Surgery

The number of bladder cancer cases in 2020 is estimated at 81,400, nearly 4.5% of all newly diagnosed cancer cases, and the current bladder cancer research market is projected to grow at a CAGR of 4.03% through 2026 White light, the most widely accepted current standard of care for bladder cancer removal, may not be … Continue reading “Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Offers Significant Advantages Over Current Standard Of Visualizing Bladder Cancer During Surgery”

NetworkNewsBreaks – Imagin Medical Inc. (CSE: IME) (OTC: IMEXF) Engages IBN, Builds Momentum for 2021

Imagin Medical (CSE: IME) (OTC: IMEXF), a surgical imaging company focused on establishing a new standard of care in visualizing cancer during minimally invasive procedures, today announced it has selected the corporate communications expertise of the InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company for private and public entities. Under the partnership, IBN will … Continue reading “NetworkNewsBreaks – Imagin Medical Inc. (CSE: IME) (OTC: IMEXF) Engages IBN, Builds Momentum for 2021”

Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Visualizes a World with Superior Bladder Cancer Surgical Procedures

Surgical imaging company Imagin Medical Inc. has developed a proprietary technology that enhances surgeons’ efforts to identify the full extent of bladder cancers and remove them Imagin’s i/Blue Imaging (TM) System uses blue light in combination with a fluorescent contrasting agent that highlights the tumor on an endoscope’s camera display to help surgeons remove the … Continue reading “Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Visualizes a World with Superior Bladder Cancer Surgical Procedures”

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 212.418.1217